Sacituzumab govitecan
HealthData.Gov
Updated Jul 6, 2026
About this dataset
TRODELVY (sacituzumab govitecan) is a prescription biologic drug manufactured by Gilead Sciences, Inc. It comes as a powder for solution, administered intravenously, with each vial containing 180 mg of the active ingredient. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Sacituzumab govitecan
Access the FDA dataset for Sacituzumab govitecan — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025